Healthcare VC Thesis

Our healthcare fund invests in BioTech, MedTech, and wellness startups with technology or founders originating from Australia. While the earliest stage we can invest in is pre-clinical, we typically follow the scientists from the very beginning. In addition to providing funding, we collaborate closely with our industrial partners to offer Chinese market access and support throughout the value chain.

Australian technology & founders

Historically, Australia has had world-class healthcare innovation. However, in the last decades, limited number of Australian healthcare companies have achieved. We believe this will be gradually improved by the transformation in the university commercialisation model, increasing numbers of healthcare investors, and strong sponsorship from the government. Our healthcare fund is dedicated to supporting BioTech, MedTech, and wellness startups with technology or founders originating from Australia.

Support from industrial partners

Deep techs require support along the value chain. While Australia can incubate top innovation, its limited market size and incomplete value chain constrain startups from scaling up. While the US market is always the first choice, we intend to provide an alternative option with support from our industrial LPs, which consist of top BioTech, MedTech, CROs and distributors in the Chinese healthcare sectors.

Megatrend driven

  • Aging population, changing lifestyles and the rise of the middle class

  • Expanding community care and health awareness

  • Precision medicine and accelerating innovation

  • Patient-centric care and the consumerization of healthcare

We leverage Australian innovation strengths to address emerging medical needs in Asia. The megatrends we identified in Asia include:

Preclinical to clinical stage

In most cases, we invest in startups after they have done preclinical research. This provide us a well-balanced risk-return profile and most importantly, a manageable number of portfolio companies to work with. However, we intend to start the conversation with the scientists at the begining of the journey and work closely with other early incubators to provide support even before we come in.